Gauff backs WTA gene-testing, while criticizing how it creates animosity toward trans community
Coco Gauff, a two-time Grand Slam champion, expressed her understanding of the WTA Tour's new gene-testing policy aimed at ensuring fairness in women's sports. However, Gauff criticized the policy's implementation, stating it has created animosity towards the transgender community.

Briefing Summary
AI-generatedCoco Gauff, a two-time Grand Slam champion, expressed her understanding of the WTA Tour's new gene-testing policy aimed at ensuring fairness in women's sports. However, Gauff criticized the policy's implementation, stating it has created animosity towards the transgender community. The WTA introduced mandatory gene-testing for all players as a requirement for the 2028 Los Angeles Olympics, focusing on the SRY gene. While the WTA asserts the policy distinguishes between biological sex and gender identity without intent to disrespect, it has faced criticism from human rights experts and activist groups. Gauff suggested the policy's introduction could have been more transparent, as some players learned about it only upon its announcement.
Article analysis
Model · rule-basedKey claims
5 extractedThe mandatory gender screening has been criticized by human rights experts and activist groups.
The WTA states the policy distinguishes between biological sex and gender identity and has no intent to disrespect anyone.
Players are being tested for the SRY gene, which indicates the presence of testes and initiates male sex development.
The WTA Tour introduced mandatory one-off gene-testing for all players for the 2028 Los Angeles Olympics.
Coco Gauff agrees with the WTA's goal of protecting fairness in women's sports but dislikes the animosity it creates towards the trans community.